Ilika's Graeme Purdy discusses scaling the Goliath solid-state battery to 10Ah, the role of the automated pilot line, manufacturing yields, and how this work supports future 50Ah development...
XP Factory CEO discusses strong interim results, highlighting a 13% increase in group sales, robust performances from Escape Hunt and Boom Battle Bar, improved EBITDA margins, and a new £20 million revolving credit facility with HSBC...
Elemental Royalty Corporation's David Cole discusses the transformative merger between Elemental Altus and EMX Royalty. Cole highlights the company’s value-driven strategy, a diversified portfolio of over 300 mineral royalty assets across 20 countries, and the key role of discovery optionality in driving long-term returns...
GSK plc has received US FDA approval for Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in patients aged 12 and over...
Diploma PLC has appointed Wilson Ng as Group Chief Financial Officer with immediate effect, following a formal internal and external selection process...
Bunzl plc has reaffirmed its 2025 adjusted operating profit guidance ahead of entering its closed period, with group revenue expected to grow by 2% to 3% at constant exchange rates...
Ilika's Graeme Purdy discusses scaling the Goliath solid-state battery to 10Ah, the role of the automated pilot line, manufacturing yields, and how this work supports future 50Ah development...
XP Factory CEO discusses strong interim results, highlighting a 13% increase in group sales, robust performances from Escape Hunt and Boom Battle Bar, improved EBITDA margins, and a new £20 million revolving credit facility with HSBC...
Elemental Royalty Corporation's David Cole discusses the transformative merger between Elemental Altus and EMX Royalty. Cole highlights the company’s value-driven strategy, a diversified portfolio of over 300 mineral royalty assets across 20 countries, and the key role of discovery optionality in driving long-term returns...
GSK plc has received US FDA approval for Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in patients aged 12 and over...
Diploma PLC has appointed Wilson Ng as Group Chief Financial Officer with immediate effect, following a formal internal and external selection process...
Bunzl plc has reaffirmed its 2025 adjusted operating profit guidance ahead of entering its closed period, with group revenue expected to grow by 2% to 3% at constant exchange rates...
